Loading…
Nkarta, Inc. is projected to rise to $4.71 by 2027, a +48% move from its current price of $3.19. NKTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.07 | $3.19 | $3.33 | +0.11% |
| May 30 | $3.02 | $3.20 | $3.39 | +0.21% |
| May 31 | $2.98 | $3.20 | $3.44 | +0.32% |
| Jun 1 | $2.95 | $3.20 | $3.48 | +0.43% |
| Jun 2 | $2.93 | $3.21 | $3.52 | +0.53% |
| Jun 3 | $2.90 | $3.21 | $3.55 | +0.64% |
| Jun 4 | $2.88 | $3.21 | $3.58 | +0.75% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.88 | $3.21 | $3.58 | +0.75% |
| Week 2 | $2.78 | $3.24 | $3.77 | +1.50% |
| Week 3 | $2.70 | $3.26 | $3.94 | +2.25% |
| Week 4 | $2.65 | $3.29 | $4.08 | +3.02% |
| Week 5 | $2.60 | $3.31 | $4.22 | +3.78% |
| Week 6 | $2.56 | $3.34 | $4.35 | +4.56% |
| Week 7 | $2.52 | $3.36 | $4.48 | +5.34% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nkarta, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.
Its lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis.
Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California. The company has a research collaboration agreement with CRISPR Therapeutics AG.
Nkarta, Inc. (NKTX) is a healthcare stock trading at $3.03 with a market cap of $216.78M.
It is ranked 3790.
Forecast highlights show upside potential across the multi-year horizon. For 2026, min $1.87, avg $3.03, max $4.83, ROI 0, sentiment NEUTRAL.
From 2027 onward, the forecast envisions rising averages and bullish sentiment, with 2027 avg $4.48, 2028 avg $4.77, 2029 avg $5.15, 2030 avg $5.06; by 2040 avg $15.33 and by 2050 avg $23.58.
A major floor 39.8% below — a decisive break under it would weaken the trend.
The nearest floor, 24.1% below — buyers have tended to step in here.
The nearest ceiling, 9.4% above — a clean break opens room to run.
A major ceiling 28.6% above — clearing it would confirm fresh momentum.
Key NKTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NKTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.02 | Buy | $3.04 | Buy |
| MA 10 | $2.90 | Buy | $2.99 | Buy |
| MA 20 | $2.98 | Buy | $2.94 | Buy |
| MA 50 | $2.67 | Buy | $2.76 | Buy |
| MA 100 | $2.47 | Buy | $2.55 | Buy |
| MA 200 | $2.25 | Buy | $2.42 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.88 | Neutral |
| Stoch RSI (14) | 81.90 | Sell |
| CCI (20) | 76.43 | Neutral |
| Williams %R (14) | -14.06 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.75 | Neutral |
| Stochastic %K (14) | 85.94 | Sell |
| TRIX (15) | 0.41 | Buy |
| Awesome (5,34) | 0.12 | Buy |
| Ultimate (7,14,28) | 78.11 | Sell |
| Momentum (10) | -0.09 | Sell |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 3.17 | Buy |
| ADX (14) | 15.60 | Neutral |
| ATR (14) | 0.11 | Info |
The 30-day technical picture is BULLISH.
RSI14 is 60; SMA50 is $2.64; SMA200 is $2.24. The current price is $3.03, and the price sits above both SMAs, suggesting positive near-term momentum. The 30-day range runs from $2.29 to $4.01, with support at $2.29 and resistance at $3.49.
Annualized volatility is 80%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.87 | $3.19 | $5.12 | 0% | Neutral | |
| $3.56 | $4.71 | $6.71 | +48% | Bullish | |
| $3.67 | $5.07 | $7.60 | +59% | Bullish | |
| $3.91 | $5.61 | $8.73 | +76% | Bullish | |
| $3.72 | $5.52 | $8.87 | +73% | Bullish | |
| $3.83 | $5.87 | $9.70 | +84% | Bullish | |
| $5.02 | $7.91 | $13.42 | +148% | Bullish | |
| $5.74 | $9.30 | $16.14 | +191% | Bullish | |
| $6.22 | $10.34 | $18.32 | +224% | Bullish | |
| $5.96 | $10.15 | $18.35 | +218% | Bullish | |
| $9.20 | $17.67 | $34.61 | +454% | Bullish | |
| $12.92 | $28.71 | $63.08 | +800% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.87 | $3.19 | $3.76 | +0.00% |
| June 2026 | $2.73 | $3.24 | $3.96 | +1.48% |
| July 2026 | $2.92 | $3.51 | $4.39 | +8.55% |
| August 2026 | $3.00 | $3.65 | $4.62 | +3.77% |
| September 2026 | $2.96 | $3.63 | $4.66 | -0.42% |
| October 2026 | $3.07 | $3.79 | $4.92 | +4.50% |
| November 2026 | $3.20 | $3.97 | $5.20 | +4.68% |
| December 2026 | $3.10 | $3.88 | $5.12 | -2.43% |
Click any year to see its month-by-month NKTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NKTX is projected to trade between $1.87 and $5.12, averaging $3.19 — a potential gain of 0% from today's $3.19. Price action looks broadly range-bound.
Nkarta, Inc.'s 2027 outlook centres on $4.71, within a $3.56 to $6.71 range. That is up +48% on the projected 2026 average. That marks a +48% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, NKTX could reach as high as $7.60, with a base case around $5.07 and support toward $3.67 — roughly +59% from $3.19. Momentum favours further upside here.
Expect NKTX to range from $3.91 to $8.73 through 2029. The $5.61 average target implies a +76% move from current prices. That is up +11% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The NKTX price prediction for 2030 points to an average of $5.52 (low $3.72, high $8.87) — a potential gain of +73% on today's $3.19. Momentum favours further upside here.
In 2031, NKTX is projected to trade between $3.83 and $9.70, averaging $5.87 — a potential gain of +84% from today's $3.19. That is up +6% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Nkarta, Inc.'s 2032 outlook centres on $7.91, within a $5.02 to $13.42 range. That is up +35% on the projected 2031 average. That marks a +148% change versus current levels. Momentum favours further upside here.
By 2033, NKTX could reach as high as $16.14, with a base case around $9.30 and support toward $5.74 — roughly +191% from $3.19. Buyers look set to stay in control over this stretch.
Expect NKTX to range from $6.22 to $18.32 through 2034. The $10.34 average target implies a +224% move from current prices. That is up +11% on the projected 2033 average. Momentum favours further upside here.
The NKTX price prediction for 2035 points to an average of $10.15 (low $5.96, high $18.35) — a potential gain of +218% on today's $3.19. Buyers look set to stay in control over this stretch.
In 2040, NKTX is projected to trade between $9.20 and $34.61, averaging $17.67 — a potential gain of +454% from today's $3.19. That is up +74% on the projected 2035 average. Momentum favours further upside here.
Nkarta, Inc.'s 2050 outlook centres on $28.71, within a $12.92 to $63.08 range. That is up +63% on the projected 2040 average. That marks a +800% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in NKTX today (≈ 313.479624 NKTX) could be worth
$9,001.03
+$8,001.03 (+800%) by 2050 · US Dollar
Based on the average projected NKTX price of $28.71 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NKTXwould be worth at today's price.
$1,000 invested in NKTX on May 27, 2025 (≈ 574.712641 NKTX) would be worth
$1,833.33
+$833.33 (+83.3%) today · 1.83× · US Dollar
Based on a NKTX entry price of $1.74 vs. today's $3.19.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.8 | $1,139.29 | +13.9% |
| 1 month ago | $2.83 | $1,127.21 | +12.7% |
| 3 months ago | $2.62 | $1,217.56 | +21.8% |
| 6 months ago | $1.89 | $1,687.83 | +68.8% |
| 1 year ago | $1.74 | $1,833.33 | +83.3% |
| All time (5.0y) ago | $24.81 | $128.58 | -87.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NKTX forecast.
Our base-case forecast reaches $6.40 around 2032.
Implied market cap at $6.40: $457.89M
The multi-year forecast paints an upside path, with the average price rising from $3.03 in 2026 to $23.58 by 2050, passing through key milestones such as $5.06 by 2030 and $15.33 by 2040.
The forecast also shows growing returns, with 2030 ROI of 66.9, 2040 ROI of 405.9, and 2050 ROI of 678.3, all accompanied by a bullish sentiment across years beyond 2026.
Tap a question to reveal the answer.
The 2030 forecast lists min $3.37, avg $5.06, max $8.22, ROI 66.9, sentiment BULLISH.
Forecasts show bullish sentiment in 2027-2050 with rising averages and ROI: 2027 avg $4.48, 2028 avg $4.77, 2029 avg $5.15, 2040 avg $15.33, 2050 avg $23.58.
Yes. The 2032 forecast lists max $12.00.
Average price $15.33, with a min $7.78 and a max $30.48; ROI 405.9; sentiment BULLISH.
Average price $23.58, range min $10.61 to max $52.71; ROI 678.3; sentiment BULLISH.
Nkarta, Inc. Community Discussion
0Share your Nkarta, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.